Spruson & Ferguson has an established practice in the biotechnology, pharmaceutical and life sciences industries.

Our patent attorneys are technically qualified in areas including genetics, biophysics, molecular biology, microbiology, biomedical engineering, chemistry and biochemistry with the majority qualified to PhD level.

With our strong network of offices across the Asia-Pacific, we are well placed to assist clients with their patent portfolios in this rapidly expanding industry.

Key Team Members View More
Beijing, China
Dr. Oliver Lutze
Principal, China Country Manager
Patents: Chemical & Life Science
+86 10 8225 5655 oliver.lutze@spruson.com
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent matters with a special focus on China activities. Oliver’s practice primarily…
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent…
Read More
Sydney, Australia
Dr. Simon Potter
Principal, Chemical / Life Sciences Leader Australia
Patents: Chemical & Life Science
+61 2 9393 0100 simon.potter@spruson.com
Simon joined Spruson & Ferguson in 2007 and is an experienced patent attorney specialising in the field of biotechnology. He completed a Bachelor degree specialising in molecular biology and…
Simon joined Spruson & Ferguson in 2007 and is an experienced patent attorney specialising in the field of biotechnology….
Read More
Singapore, Singapore
Dr. Soo Ee Lin
Principal, Director Malaysia
Patents: Life Science
+65 6333 7200 eelin.soo@spruson.com
Ee Lin holds a Bachelor of Technology degree with First Class Honours in Biotechnology from the University of Auckland, where, during the course of her studies, she was engaged…
Ee Lin holds a Bachelor of Technology degree with First Class Honours in Biotechnology from the University of Auckland,…
Read More
Latest News & Insights
China Government Releases New Regulation on Human Genetic Resource
On May 28, 2019, China’s State Council releases a new Regulation of Human Genetic Resources (the “Regulation”) which will become effective on July 1. For the life sciences industry and research organizations…
On May 28, 2019, China’s State Council releases a new Regulation of Human Genetic Resources (the “Regulation”) which will become effective on…
Read More
Pharmaceutical patents: Fighting a $25 million claim for damages
A recent Full Federal Court decision in Australia provides a useful insight as to how a Court in Australia will calculate damages in proceedings concerning the infringement of a…
A recent Full Federal Court decision in Australia provides a useful insight as to how a Court in Australia…
Read More

Contact our Expert Team

Contact Us